Search results
Results from the WOW.Com Content Network
They're both innovative biotechs working in relatively newer niches of this booming industry. However, they've moved in the wrong direction this year. CRISPR's shares are down by 27% year to date ...
Alnylam (ALNY): pioneering a new class of therapeutics based on RNA interference and a better fit for collaboration partner Novartis (NYSE:NVS) BioMarin (NASDAQ:BMRN): a rare disease gene therapy ...
Infrastructure, robotics, biotech Silicene: Early research Nanoscale electronics Superalloy: Research, diffusion Significantly stronger metal components (particularly in aircraft jet engines) Synthetic diamond: Research, commercialization Electronics Time crystal: Research experiments [86] Quantum computers with stable qubits: Translucent concrete
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The company burned through an average of $54 million in 2022 and 2023. Prior to the IPO, it had $62 million in cash and equivalents on its balance sheet. The IPO raised approximately $167 million.
For premium support please call: 800-290-4726 more ways to reach us
Biobased economy, bioeconomy or biotechonomy is an economic activity involving the use of biotechnology and biomass in the production of goods, services, or energy. The terms are widely used by regional development agencies, national and international organizations, and biotechnology companies.